Lex Diagnostics, Ltd.
LEX Diagnostics is a privately held molecular diagnostics company focused on developing ultra-fast, high-sensitivity PCR point-of-care testing systems. Their mission is to redefine point-of-care diagnostics by delivering clinical insights within minutes, supporting healthcare providers with lab-quality results in a user-friendly system. They aim to improve patient care through rapid, accurate, and accessible molecular testing, with a focus on infectious diseases such as COVID-19, Influenza, Strep A, and RSV.
Industries
Nr. of Employees
small (1-50)
Lex Diagnostics, Ltd.
Melbourn, Cambridgeshire, United Kingdom, Europe
Products
Ultra-fast point-of-care PCR system (instrument and cartridge assays)
An integrated point-of-care molecular diagnostic platform comprising a compact instrument and single-use cartridges that performs multiplex PCR directly from swab samples with automated, no-liquid-handling workflow and time-to-result reported in approximately 6–10 minutes.
Ultra-fast point-of-care PCR system (instrument and cartridge assays)
An integrated point-of-care molecular diagnostic platform comprising a compact instrument and single-use cartridges that performs multiplex PCR directly from swab samples with automated, no-liquid-handling workflow and time-to-result reported in approximately 6–10 minutes.
Expertise Areas
- Point-of-care molecular diagnostics
- Assay development for respiratory syndromic testing
- Reagent formulation and lyophilisation
- Consumables manufacturing and scale-up
Key Technologies
- Rapid thermal cycling for PCR
- Multiplex PCR assays
- Cartridge-based sample-to-answer systems
- Swab-to-result automated workflows